Clinical Features, Diagnosis, and Outcome of Encephalitis in French Guiana.
Adolescent
Adult
Cryptococcosis
/ epidemiology
Cryptococcus
/ isolation & purification
Encephalitis
/ epidemiology
Female
French Guiana
/ epidemiology
Glasgow Outcome Scale
Humans
Incidence
Male
Meningoencephalitis
/ epidemiology
Middle Aged
Pneumococcal Infections
/ epidemiology
Respiration, Artificial
Retrospective Studies
Streptococcus pneumoniae
/ isolation & purification
Survival Analysis
Toxoplasma
/ isolation & purification
Toxoplasmosis
/ epidemiology
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
pubmed:
19
12
2018
medline:
18
12
2019
entrez:
19
12
2018
Statut:
ppublish
Résumé
The aim of our study was to describe the clinical features, the etiologies, and the factors associated with poor outcome of encephalitis in French Guiana. Our study was retrospective, including all cases of encephalitis hospitalized in the Cayenne General Hospital, from January 2007 to July 2017. Patients were included through the 2013 encephalitis consortium criteria and the outcome was evaluated using the Glasgow outcome scale at 3 months from the diagnosis of encephalitis. We included 108 patients, giving an approximate incidence rate of four cases/100,000 inhabitants/year. The origin of the encephalitis was diagnosed in 81 cases (75%), and 72 of them (66.7%) were from an infectious origin. The most common infectious causes were
Identifiants
pubmed: 30560767
doi: 10.4269/ajtmh.18-0308
pmc: PMC6367637
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
452-459Références
J Clin Neurol. 2016 Jan;12(1):1-13
pubmed: 26754777
J Clin Med. 2013 Dec 17;2(4):328-30
pubmed: 26237151
Clin Microbiol Infect. 2011 Apr;17(4):621-6
pubmed: 20518796
Ann Cardiol Angeiol (Paris). 2014 Jun;63(3):155-62
pubmed: 24958528
PLoS One. 2014 Sep 05;9(9):e104169
pubmed: 25192177
PLoS Negl Trop Dis. 2016 Nov 1;10(11):e0005081
pubmed: 27802275
Crit Care. 2010;14(6):R240
pubmed: 21194480
Am J Trop Med Hyg. 2001 May-Jun;64(5-6):274-9
pubmed: 11463116
PLoS Negl Trop Dis. 2013 Jun 27;7(6):e2258
pubmed: 23826400
Neurology. 2007 Apr 17;68(16 Suppl 2):S23-36
pubmed: 17438235
Lancet Neurol. 2016 Apr;15(4):391-404
pubmed: 26906964
PLoS One. 2017 Feb 14;12(2):e0172267
pubmed: 28196111
Neurology. 2014 Feb 4;82(5):443-51
pubmed: 24384647
Comp Immunol Microbiol Infect Dis. 2018 Feb;56:34-38
pubmed: 29406281
Neurology. 2013 Aug 27;81(9):793-800
pubmed: 23892708
Neuropsychol Rehabil. 2007 Aug-Oct;17(4-5):406-28
pubmed: 17676528
Lancet Neurol. 2013 Feb;12(2):157-65
pubmed: 23290630
PLoS Negl Trop Dis. 2017 Jun 30;11(6):e0005715
pubmed: 28665957
Emerg Infect Dis. 2015 Feb;21(2):280-9
pubmed: 25627940
Clin Infect Dis. 2006 Dec 15;43(12):1565-77
pubmed: 17109290
Mem Inst Oswaldo Cruz. 2004 Dec;99(8):805-8
pubmed: 15761594
Clin Infect Dis. 2009 Dec 15;49(12):1838-47
pubmed: 19929384
Epidemiol Infect. 2013 Nov;141(11):2256-68
pubmed: 23168268
Int J STD AIDS. 2010 May;21(5):359-61
pubmed: 20498108
PLoS Med. 2007 Feb;4(2):e21
pubmed: 17284154
Lancet Neurol. 2014 Nov;13(11):1139-1151
pubmed: 25316020
Am J Trop Med Hyg. 2002 Feb;66(2):200-7
pubmed: 12135294
Cold Spring Harb Perspect Med. 2014 Jul 01;4(7):a019760
pubmed: 24985132
Lancet Infect Dis. 2015 Mar;15(3):348-55
pubmed: 25467646
Med Mal Infect. 2017 May;47(3):221-235
pubmed: 28341533
Clin Infect Dis. 2013 Oct;57(8):1114-28
pubmed: 23861361
Arch Dis Child. 2005 Nov;90(11):1188-9
pubmed: 16243873
Emerg Infect Dis. 2013;19(9):
pubmed: 23969035
Lancet Infect Dis. 2004 Jun;4(6):337-48
pubmed: 15172342
Med Mycol. 2011 Nov;49(8):864-71
pubmed: 21612563
Clin Infect Dis. 2012 May;54(10):1455-64
pubmed: 22460967
Clin Neurol Neurosurg. 2013 Sep;115(9):1753-61
pubmed: 23643180
Curr Opin Neurol. 2015 Jun;28(3):277-82
pubmed: 25887770
Lancet Infect Dis. 2010 Dec;10(12):835-44
pubmed: 20952256